The Pennant Group (NASDAQ:PNTG – Get Free Report) will be posting its quarterly earnings results after the market closes on Wednesday, November 6th. Analysts expect The Pennant Group to post earnings of $0.19 per share for the quarter. The Pennant Group has set its FY 2024 guidance at 0.890-0.950 EPS.Individual that are interested in participating in the company’s earnings conference call can do so using this link.
The Pennant Group (NASDAQ:PNTG – Get Free Report) last issued its quarterly earnings data on Tuesday, August 6th. The company reported $0.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.17 by $0.02. The firm had revenue of $168.75 million during the quarter, compared to analysts’ expectations of $156.71 million. The Pennant Group had a net margin of 3.16% and a return on equity of 13.74%. On average, analysts expect The Pennant Group to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
The Pennant Group Stock Up 1.8 %
Shares of NASDAQ PNTG opened at $33.99 on Wednesday. The stock has a market capitalization of $1.03 billion, a P/E ratio of 62.94, a P/E/G ratio of 3.44 and a beta of 2.01. The company has a 50-day moving average price of $34.01 and a 200-day moving average price of $27.87. The Pennant Group has a 1 year low of $10.46 and a 1 year high of $37.13. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.12 and a quick ratio of 1.12.
Wall Street Analysts Forecast Growth
Read Our Latest Stock Analysis on The Pennant Group
The Pennant Group Company Profile
The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.
Featured Stories
- Five stocks we like better than The Pennant Group
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Is McDonald’s Stock a Smart Buy After Sell-Off and Earnings?
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- QuantumScape: Solid State EV Batteries Nearing Commercialization
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- MicroStrategy: Is This Bitcoin-Powered Stock a Buy or a Gamble?
Receive News & Ratings for The Pennant Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Pennant Group and related companies with MarketBeat.com's FREE daily email newsletter.